Cargando…

VEP Score of a Left Eye Had Predictive Values for Achieving NEDA-3 over Ten Years in Patients with Multiple Sclerosis

Background: The aim of this study was to determine the predictive value of visual evoked potentials (VEPs) in patients with relapsing–remitting multiple sclerosis (RRMS) in achieving no evidence of disease activity-3 (NEDA-3) during up to 10 years of first-line immunomodulatory therapy and to determ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miletic-Drakulic, Svetlana, Miloradovic, Ivana, Jankovic, Vladimir, Azanjac-Arsic, Ana, Lazarevic, Snezana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696926/ https://www.ncbi.nlm.nih.gov/pubmed/36433445 http://dx.doi.org/10.3390/s22228849

Ejemplares similares

How to make a decision on the choice of therapy for multiple sclerosis with sarcoidosis comorbidity?
por: Miletic-Drakulic, Svetlana D., et al.
Publicado: (2022)

Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis
por: Rotstein, Dalia, et al.
Publicado: (2022)

NEDA—NEutron Detector Array
por: Valiente-Dobón, J J, et al.
Publicado: (2019)

No Evidence of Disease Activity (NEDA) in Multiple Sclerosis - Shifting the Goal Posts
por: Pandit, Lekha
Publicado: (2019)

Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis
por: Prosperini, Luca, et al.
Publicado: (2021)

aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis
por: Häußler, Vivien, et al.
Publicado: (2021)

Evidence of disease control: a realistic concept beyond NEDA in the treatment of multiple sclerosis
por: Londoño, Ana C., et al.
Publicado: (2017)

Code-VEP vs. Eye Tracking: A Comparison Study
por: Nezamfar, Hooman, et al.
Publicado: (2018)

Multifocal VEP (mfVEP) reveals abnormal neuronal delays in diabetes
por: Wolff, Brian E., et al.
Publicado: (2010)

Effectiveness of Natalizumab in Achieving No Evidence of Disease Activity (NEDA-3)—Data From a Local Norwegian Cohort
por: Jaklin, Andreas K., et al.
Publicado: (2021)

Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis
por: Hänninen, Katariina, et al.
Publicado: (2019)

A computer-aided diagnosis of multiple sclerosis based on mfVEP recordings
por: de Santiago, Luis, et al.
Publicado: (2019)

Colored filters enhancing visual evoked potential (VEP) response in multiple sclerosis
por: Yadav, Naveen K., et al.
Publicado: (2022)

NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis
por: Puthenparampil, Marco, et al.
Publicado: (2018)

Clinical predictors of NEDA-3 one year after diagnosis of pediatric multiple sclerosis: an exploratory single-center study
por: Palavra, Filipe, et al.
Publicado: (2023)

Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study
por: Amato, Maria Pia, et al.
Publicado: (2023)

No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review]
por: Newsome, Scott D., et al.
Publicado: (2023)

P-VEP as Predictor of Occlusion Therapy
por: Singh, Satendra, et al.
Publicado: (2009)

Facility for V.E.P. and Hbar
por: Rossi, L
Publicado: (1990)

VEP Correlates of Feedback in Human Cortex
por: Petrov, Yury, et al.
Publicado: (2012)

VEP Responses to Op-Art Stimuli
por: O’Hare, Louise, et al.
Publicado: (2015)

VEP examination with new portable device
por: Kuba, Miroslav, et al.
Publicado: (2022)

Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis
por: Kappos, Ludwig, et al.
Publicado: (2015)

Long-term evaluation of NEDA-3 status in relapsing-remitting multiple sclerosis patients after switching from natalizumab to fingolimod
por: Diem, Lara, et al.
Publicado: (2018)

miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod
por: Gonzalez-Martinez, Alicia, et al.
Publicado: (2023)

Potential Drug-drug Interactions in Acute Ischemic Stroke Patients at the Neurological Intensive Care Unit
por: Aleksic, Dejan Z., et al.
Publicado: (2019)

The New Neutron Multiplicity Filter NEDA and Its First Physics Campaign with AGATA
por: Jaworski, G, et al.
Publicado: (2019)

VEP Oscillation Solutions to the Solar Neutrino Problem
por: D'Olivo, J C
Publicado: (2000)

Blue–Yellow VEP with Projector-Stimulation in Glaucoma
por: Dussan Molinos, Laura, et al.
Publicado: (2021)

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a
por: Havrdová, Eva, et al.
Publicado: (2018)

Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population
por: Simonsen, Cecilia Smith, et al.
Publicado: (2022)

A Preliminary Study on the Meaning of Inflammatory Indexes in MS: A Neda-Based Approach
por: Bunul, Sena Destan, et al.
Publicado: (2023)

Toward New Modalities in VEP-Based BCI Applications Using Dynamical Stimuli: Introducing Quasi-Periodic and Chaotic VEP-Based BCI
por: Shirzhiyan, Zahra, et al.
Publicado: (2020)

The effect of spectral filters on VEP and alpha-wave responses
por: Willeford, Kevin T., et al.
Publicado: (2016)

The changing shape of the ISCEV standard pattern onset VEP
por: Thompson, Dorothy A., et al.
Publicado: (2017)

VEP estimation of visual acuity: a systematic review
por: Hamilton, Ruth, et al.
Publicado: (2020)

Diastolic dysfunction and mortality in 436 360 men and women: the National Echo Database Australia (NEDA)
por: Playford, David, et al.
Publicado: (2020)

Diagnosis of Normal and Abnormal Color Vision with Cone-Specific VEPs
por: Rabin, Jeff C., et al.
Publicado: (2016)

Single-Trial Sparse Representation-Based Approach for VEP Extraction
por: Yu, Nannan, et al.
Publicado: (2016)

Detection of Amblyopia Using Sweep VEP Vernier and Grating Acuity
por: Hou, Chuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eqtpl8kr0dejh6sql7ov3u7o6c